These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 961236)

  • 21. Identification of a 33 kDa antigen associated with an adhesive and colonizing strain of Vibrio cholerae El Tor and its role in protection.
    Jacob A; Sinha VB; Sahib MK; Srivastava R; Kaper JB; Srivastava BS
    Vaccine; 1993; 11(3):376-82. PubMed ID: 8447165
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sublingual Adjuvant Delivery by a Live Attenuated Vibrio cholerae-Based Antigen Presentation Platform.
    Liao J; Gibson JA; Pickering BS; Watnick PI
    mSphere; 2018 Jun; 3(3):. PubMed ID: 29875145
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of toll-like receptor 4 in the proinflammatory response to Vibrio cholerae O1 El tor strains deficient in production of cholera toxin and accessory toxins.
    Haines GK; Sayed BA; Rohrer MS; Olivier V; Satchell KJ
    Infect Immun; 2005 Sep; 73(9):6157-64. PubMed ID: 16113340
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protective activity of cholera vaccines against E1 Tor cholera vibrios.
    PITTMAN M; FEELEY JC
    Bull World Health Organ; 1963; 28(3):379-83. PubMed ID: 13943861
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transcutaneous immunization with toxin-coregulated pilin A induces protective immunity against Vibrio cholerae O1 El Tor challenge in mice.
    Rollenhagen JE; Kalsy A; Cerda F; John M; Harris JB; Larocque RC; Qadri F; Calderwood SB; Taylor RK; Ryan ET
    Infect Immun; 2006 Oct; 74(10):5834-9. PubMed ID: 16988262
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A one dose experimental cholera vaccine.
    Muse M; Grandjean C; Wade TK; Wade WF
    FEMS Immunol Med Microbiol; 2012 Oct; 66(1):98-115. PubMed ID: 22612159
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Texas Star-SR: attenuated "Vibrio cholerae" oral vaccine candidate.
    Levine MM; Black RE; Clements ML; Young CR; Lanata C; Sears S; Honda T; Finkelstein R
    Dev Biol Stand; 1983; 53():59-65. PubMed ID: 6873477
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Live Attenuated Cholera Vaccine CVD 103-HgR Primes Responses to the Toxin-Coregulated Pilus Antigen TcpA in Subjects Challenged with Wild-Type Vibrio cholerae.
    Mayo-Smith LM; Simon JK; Chen WH; Haney D; Lock M; Lyon CE; Calderwood SB; Kirkpatrick BD; Cohen M; Levine MM; Gurwith M; Harris JB
    Clin Vaccine Immunol; 2017 Jan; 24(1):. PubMed ID: 27847368
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PRELIMINARY STUDIES ON THE DEVELOPMENT OF A LIVE ORAL VACCINE FOR ANTI-CHOLERA IMMUNIZATION.
    MUKERJEE S
    Bull World Health Organ; 1963; 29(6):753-66. PubMed ID: 14107748
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of antigen form and the induction of an intestinal immune response to cholera toxin/toxoid in rats.
    Pierce NF
    Adv Exp Med Biol; 1978; 107():439-45. PubMed ID: 742499
    [No Abstract]   [Full Text] [Related]  

  • 31. Culture conditions for stimulating cholera toxin production by Vibrio cholerae O1 El Tor.
    Iwanaga M; Yamamoto K; Higa N; Ichinose Y; Nakasone N; Tanabe M
    Microbiol Immunol; 1986; 30(11):1075-83. PubMed ID: 3543624
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cholera toxin modulates the systemic immune responses against Vibrio cholerae surface antigens after repeated inoculations.
    Fernandez-Miyakawa ME; Brero ML; Mateo NA
    Microbiol Immunol; 2006; 50(8):607-19. PubMed ID: 16924145
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The major subunit of the toxin-coregulated pilus TcpA induces mucosal and systemic immunoglobulin A immune responses in patients with cholera caused by Vibrio cholerae O1 and O139.
    Asaduzzaman M; Ryan ET; John M; Hang L; Khan AI; Faruque AS; Taylor RK; Calderwood SB; Qadri F
    Infect Immun; 2004 Aug; 72(8):4448-54. PubMed ID: 15271902
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prolonged colonization of mice by Vibrio cholerae El Tor O1 depends on accessory toxins.
    Olivier V; Salzman NH; Satchell KJ
    Infect Immun; 2007 Oct; 75(10):5043-51. PubMed ID: 17698571
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The toxin-coregulated pilus is a colonization factor and protective antigen of Vibrio cholerae El Tor.
    Voss E; Manning PA; Attridge SR
    Microb Pathog; 1996 Mar; 20(3):141-53. PubMed ID: 8965675
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Emergence and genetic diversity of El Tor Vibrio cholerae O1 that possess classical biotype ctxB among travel-associated cases of cholera in Japan.
    Morita M; Ohnishi M; Arakawa E; Yamamoto S; Nair GB; Matsushita S; Yokoyama K; Kai A; Seto K; Watanabe H; Izumiya H
    J Med Microbiol; 2010 Jun; 59(Pt 6):708-712. PubMed ID: 20223896
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phylogenetic Diversity of Vibrio cholerae Associated with Endemic Cholera in Mexico from 1991 to 2008.
    Choi SY; Rashed SM; Hasan NA; Alam M; Islam T; Sadique A; Johura FT; Eppinger M; Ravel J; Huq A; Cravioto A; Colwell RR
    mBio; 2016 Mar; 7(2):e02160. PubMed ID: 26980836
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of Vibrio cholerae O139 synonym Bengal isolated from patients with cholera-like disease in Bangladesh.
    Higa N; Honma Y; Albert MJ; Iwanaga M
    Microbiol Immunol; 1993; 37(12):971-4. PubMed ID: 8133802
    [TBL] [Abstract][Full Text] [Related]  

  • 39. AGGLUTINATING, LETHAL TOXIN AND E1 TOR HAEMOLYSIN NEUTRALIZING POTENCY OF SERA IN CHOLERA.
    FELSENFELD O; NASUNIYA N; WATANABE Y; PENA A; DALE BN
    Bull World Health Organ; 1964; 30(6):833-44. PubMed ID: 14215189
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oral administration of one dose of cholera toxin induces a systemic immune response prior to a mucosal immune response by a direct presentation in the spleen.
    Benedetti R; Lev P; Massouh E; Fló J
    Immunol Lett; 1998 Feb; 60(2-3):149-56. PubMed ID: 9557957
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.